Ontario, Canada

12% Raised

Short Summary

123Genetix is an innovative for-profit social enterprise that uses an artificial intelligence/machine learning platform to build computer stem cell simulations that empower global research leading to effective treatments for rare and other diseases.


Investment Raised
Previous Rounds N/A
Stage MVP/Finished Product
Investor Role Weekly Involvement


  • We have already completed and published 18 rare disease simulations on line
  • We have 3 research programs initiated with Key Opinion Leaders
  • Overview of 123Genetix’s technology – in Orphanet Journal of Rare Diseases
  • Intellectual Property strategy initiated for first potential drug candidate
  • Recipient of BURST grant (60,000 CAD), March, 2019, (TECHALLIANCE, London)
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
0% raised

Disease Diagnostics

location_on India

The business consists of 3 main products: a diagnostic kit, image analysis software, and lab on tab hardware. In total, they combine to form a powerful all in one platform to diagnose any known disease via a novel technology developed by me earlier.

C$ 500,000


C$ 50,000

Min per Investor

0% raised

Space Mining Project

location_on New Brunswick, Canada

OrbitingUp; Creating a cost-effective way to mine Asteroids. Market potential of over $400t; Targeting a total revenue of $600b by 2028; 3D model of Asteroid Mining Machine & Propulsive Lander already created; Targeting 50+ million worldwide.

C$ 3,000,000


C$ 10,000

Min per Investor

Global Pro
0% raised

Izotropic Corporation

location_on British Columbia, Canada

With our dedicated breast CT imaging system, Izotropic Corporation intends to challenge mammography, tomosynthesis, ultrasound and MRI; the most recognized breast imaging modalities currently used for screening and diagnosing breast cancers.

C$ 5,000,000


C$ 25,000

Min per Investor

load one similar proposal